Abstract
Introduction Current guidelines recommend cardiac resynchronisation therapy (CRT) in patients with severe symptomatic heart failure, depressed left ventricular (LV) systolic function and a wide QRS complex (>= 120 ms). However, patients with heart failure having a narrow QRS complex might also benefit from CRT.
Design setting patients interventions During the Predictors of Response to Cardiac Resynchronisation Therapy (PROSPECT) trial, 41 patients were enrolled in a 'narrow' QRS sub-study. These patients had a QRS complex
Original language | English |
---|---|
Pages (from-to) | 1107 - 1113 |
Number of pages | 7 |
Journal | Heart |
Volume | 96 |
Issue number | 14 |
DOIs | |
Publication status | Published - Jul 2010 |